Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rudin

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|May 17, 2005
An elective single autograft with high-dose melphalan: single-center study of 451 patientsB Sirohi, R Powles, J Mehta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha2bB Sirohi, R Powles, D Lawrence, et al.
European Journal of Pediatrics|November 1, 2001
Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitorsF Steiner, C Kind, C Aebi, et al.
Tropical and Geographical Medicine|January 1, 1992
Evaluation of 5.1-[NANP]19, a recombinant Plasmodium falciparum vaccine candidate, in adultsD Stürchler, M Just, R Berger, et al.
Bone Marrow Transplantation|August 11, 2001
Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteriaB Sirohi, R Powles, S Kulkarni, et al.
British Journal of Cancer|August 7, 2001
Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myelomaB Sirohi, R Powles, S Kulkarni, et al.
AIDS (London, England)|February 19, 1998
Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study GroupC Kind, C Rudin, C A Siegrist, et al.
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1995
[Congenital toxoplasmosis: pediatric approach. Consensus report of the Swiss infectious disease pediatricians]B Vaudaux, C Rudin, C Kind, et al.
The American Journal of Tropical Medicine and Hygiene|October 1, 1995
Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adultsD Sturchler, R Berger, C Rudin, et al.
Hospital & Community Psychiatry|December 1, 1991
Evaluation of a Maryland fiscal incentive plan for placing state hospital patients in nursing homesB J Burns, J E Taube, T Permutt, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|May 17, 2005
An elective single autograft with high-dose melphalan: single-center study of 451 patientsB Sirohi, R Powles, J Mehta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha2bB Sirohi, R Powles, D Lawrence, et al.
European Journal of Pediatrics|November 1, 2001
Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitorsF Steiner, C Kind, C Aebi, et al.
Tropical and Geographical Medicine|January 1, 1992
Evaluation of 5.1-[NANP]19, a recombinant Plasmodium falciparum vaccine candidate, in adultsD Stürchler, M Just, R Berger, et al.
Bone Marrow Transplantation|August 11, 2001
Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteriaB Sirohi, R Powles, S Kulkarni, et al.
British Journal of Cancer|August 7, 2001
Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myelomaB Sirohi, R Powles, S Kulkarni, et al.
AIDS (London, England)|February 19, 1998
Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study GroupC Kind, C Rudin, C A Siegrist, et al.
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1995
[Congenital toxoplasmosis: pediatric approach. Consensus report of the Swiss infectious disease pediatricians]B Vaudaux, C Rudin, C Kind, et al.
The American Journal of Tropical Medicine and Hygiene|October 1, 1995
Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adultsD Sturchler, R Berger, C Rudin, et al.
Hospital & Community Psychiatry|December 1, 1991
Evaluation of a Maryland fiscal incentive plan for placing state hospital patients in nursing homesB J Burns, J E Taube, T Permutt, et al.
Pageof 8